Cronos Group (CRON) Competitors

Crinetics Pharmaceuticals (NASDAQ:CRNX) and Cronos Group (NASDAQ:CRON) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Which has better earnings and valuation, CRNX or CRON?

Cronos Group has higher revenue and earnings than Crinetics Pharmaceuticals. Crinetics Pharmaceuticals is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crinetics Pharmaceuticals	$760K	3,864.66	-$214.53M	-$3.82	-8.21
Cronos Group	$124.59M	6.47	-$73.96M	$0.13	16.08

Do analysts prefer CRNX or CRON?

Crinetics Pharmaceuticals presently has a consensus price target of $73.00, indicating a potential upside of 132.71%. Given Crinetics Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Crinetics Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crinetics Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.92
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media prefer CRNX or CRON?

In the previous week, Crinetics Pharmaceuticals had 12 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Crinetics Pharmaceuticals and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.45 beat Crinetics Pharmaceuticals' score of 0.99 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Crinetics Pharmaceuticals	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, CRNX or CRON?

Crinetics Pharmaceuticals has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in CRNX or CRON?

98.5% of Crinetics Pharmaceuticals shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 4.6% of Crinetics Pharmaceuticals shares are held by insiders. Comparatively, 7.3% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community favor CRNX or CRON?

Cronos Group received 305 more outperform votes than Crinetics Pharmaceuticals when rated by MarketBeat users. However, 69.43% of users gave Crinetics Pharmaceuticals an outperform vote while only 61.13% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Crinetics Pharmaceuticals	Outperform Votes 159 69.43%	Underperform Votes 70 30.57%
Cronos Group	Outperform Votes 464 61.13%	Underperform Votes 295 38.87%

Is CRNX or CRON more profitable?

Crinetics Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Crinetics Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crinetics Pharmaceuticals	N/A	-36.12%	-31.89%
Cronos Group	-42.65%	-2.56%	-2.47%

Summary

Crinetics Pharmaceuticals and Cronos Group tied by winning 9 of the 18 factors compared between the two stocks.